Literature DB >> 8113671

Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.

J Thibodeau1, N Labrecque, F Denis, B T Huber, R P Sékaly.   

Abstract

Bacterial and retroviral superantigens (SAGs) interact with major histocompatibility complex (MHC) class II molecules and stimulate T cells upon binding to the V beta portion of the T cell receptor. Whereas both types of molecules exert similar effects on T cells, they have very different primary structures. Amino acids critical for the binding of bacterial toxins to class II molecules have been identified but little is known of the molecular interactions between class II and retroviral SAGs. To determine whether both types of superantigens interact with the same regions of MHC class II molecules, we have generated mutant HLA-DR molecules which have lost the capacity to bind three bacterial toxins (Staphylococcus aureus enterotoxin A [SEA], S. aureus enterotoxin B [SEB], and toxic shock syndrome toxin 1 [TSST-1]). Cells expressing these mutated class II molecules efficiently presented two retroviral SAGs (Mtv-9 and Mtv-7) to T cells while they were unable to present the bacterial SAGs. These results demonstrate that the binding sites for both types of SAGs can be dissociated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113671      PMCID: PMC2191396          DOI: 10.1084/jem.179.3.1029

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Maximal expression of recombinant cDNAs in COS cells for use in expression cloning.

Authors:  F W Kluxen; H Lübbert
Journal:  Anal Biochem       Date:  1993-02-01       Impact factor: 3.365

4.  Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens.

Authors:  U Landegren
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

5.  Cell cycle regulation of mouse H3 histone mRNA metabolism.

Authors:  R B Alterman; S Ganguly; D H Schulze; W F Marzluff; C L Schildkraut; A I Skoultchi
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

6.  An endogenous retrovirus mediating deletion of alpha beta T cells?

Authors:  D L Woodland; M P Happ; K J Gollob; E Palmer
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

7.  Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.

Authors:  M Subramanyam; B McLellan; N Labrecque; R P Sekaly; B T Huber
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

8.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  The role of L3T4 in recognition of Ia by a cytotoxic, H-2Dd-specific T cell hybridoma.

Authors:  J L Greenstein; J Kappler; P Marrack; S J Burakoff
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

10.  Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes.

Authors:  M A Norcross; D M Bentley; D H Margulies; R N Germain
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  11 in total

1.  Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Authors:  F Denis; N H Shoukry; M Delcourt; J Thibodeau; N Labrecque; H McGrath; J S Munzer; N G Seidah; R P Sékaly
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.

Authors:  S Bavari; R G Ulrich
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

3.  Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.

Authors:  P M Lavoie; J Thibodeau; I Cloutier; R Busch; R P Sékaly
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Major histocompatibility complex class II binding site for streptococcal pyrogenic (erythrogenic) toxin A.

Authors:  U F Hartwig; D Gerlach; B Fleischer
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

6.  Different superantigens interact with distinct sites in the Vbeta domain of a single T cell receptor.

Authors:  S C Hong; G Waterbury; C A Janeway
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 7.  Role of the T cell receptor alpha-chain in superantigen recognition.

Authors:  M A Blackman; D L Woodland
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

8.  Highly biased CDR3 usage in restricted sets of beta chain variable regions during viral superantigen 9 response.

Authors:  C Ciurli; D N Posnett; R P Sékaly; F Denis
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

9.  T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.

Authors:  N Labrecque; J Thibodeau; W Mourad; R P Sékaly
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.

Authors:  J M Hurley; R Shimonkevitz; A Hanagan; K Enney; E Boen; S Malmstrom; B L Kotzin; M Matsumura
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.